Genenta Science
  • who we are
  • our companies
  • stories
  • investors
Select Page

Genenta l’anti cancro debutta al Nasdaq

Mar 13, 2026

la cinese QZ guida gli investimenti

Sep 11, 2019

Start up italiane a caccia di 100 milioni a New York

Apr 5, 2019

Tumori, Paracchi (Genenta Science) vince il premio dedicato ai pazienti-imprenditori

Mar 22, 2019

Salute, numeri da record-verso mercato da 10 miliardi

Sep 19, 2017

« Older Entries
Next Entries »
CONTACT
NEWSROOM
© 2026 Genenta Science. All Rights Reserved - Terms and conditions - Privacy Policy - Whistleblowing - P.IVA 08738490963